Human Investing LLC Amgen Inc Transaction History

Human Investing LLC

$550 Million
Q3 2024

A detailed history of Human Investing LLC transactions in Amgen Inc stock. As of the latest transaction made, Human Investing LLC holds 4,702 shares of AMGN stock, worth $1.31 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

4,702

Previous 4,748 0.97%

Holding current value

$1.31 Million

Previous $1.48 Million 2.16%

% of portfolio

0.28%

Previous 0.29%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$309.38 - $337.38 $14,231 - $15,519	-46 Reduced 0.97%	4,702 $1.52 Million
Q2 2024 Jul 17, 2024	SELL	$262.75 - $319.31 $97,217 - $118,144	-370 Reduced 7.23%	4,748 $1.48 Million
Q1 2024 Apr 25, 2024	SELL	$268.87 - $324.56 $39,523 - $47,710	-147 Reduced 2.79%	5,118 $1.46 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $407,330 - $459,516	-1,593 Reduced 23.23%	5,265 $1.52 Million
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $448,013 - $556,221	2,049 Added 42.61%	6,858 $1.84 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $71,137 - $84,118	-332 Reduced 6.46%	4,809 $1.07 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $198,920 - $242,451	-881 Reduced 14.63%	5,141 $1.24 Million
Q4 2022 Jan 27, 2023	SELL	$229.03 - $291.01 $335,757 - $426,620	-1,466 Reduced 19.58%	6,022 $0
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $39,729 - $44,807	-177 Reduced 2.31%	7,488 $1.69 Million
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $34,606 - $38,511	-150 Reduced 1.92%	7,665 $1.87 Million
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $1.71 Million - $1.9 Million	7,815 New	7,815 $1.89 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $1.66 Million - $1.9 Million	-8,366 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$212.27 - $248.7 $3,396 - $3,979	16 Added 0.19%	8,366 $1.78 Million
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $34,569 - $38,352	148 Added 1.8%	8,350 $2.04 Million
Q1 2021 May 05, 2021	SELL	$221.91 - $258.6 $146,460 - $170,676	-660 Reduced 7.45%	8,202 $2.04 Million
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $96,721 - $115,178	-447 Reduced 4.8%	8,862 $2.04 Million
Q3 2020 Oct 27, 2020	SELL	$234.65 - $260.95 $88,463 - $98,378	-377 Reduced 3.89%	9,309 $2.37 Million
Q2 2020 Jul 22, 2020	SELL	$197.81 - $242.74 $206,118 - $252,935	-1,042 Reduced 9.71%	9,686 $2.29 Million
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $254,771 - $337,896	-1,398 Reduced 11.53%	10,728 $2.18 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $77,576 - $99,712	-410 Reduced 3.27%	12,126 $2.92 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $810,830 - $971,543	4,657 Added 59.11%	12,536 $2.43 Million
Q2 2019 Aug 16, 2019	BUY	$166.7 - $195.41 $1.04 Million - $1.22 Million	6,227 Added 376.94%	7,879 $1.45 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $6,149 - $6,931	34 Added 2.1%	1,652 $314,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $288,651 - $336,948	1,618 New	1,618 $315,000

Others Institutions Holding AMGN

# of Institutions

3,078

Shares Held

405M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Human Investing LLC with notifications on news.

Account

Human Investing LLC Amgen Inc Transaction History